Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
An. bras. dermatol ; 89(2): 266-272, Mar-Apr/2014. tab, graf
Article in English | LILACS | ID: lil-706985

ABSTRACT

BACKGROUND: Leprosy can have its course interrupted by type 1 and 2 reactional episodes, the last named of erythema nodosum leprosum (ENL). Thalidomide has been the medication of choice for the control of ENL episodes since 1965. OBJECTIVES: These episodes can repeat and cause damages to the patient. In order to prevent these episodes, an extra dose of 100 mg/day thalidomide was used during six months, followed by a follow-up period of six more months after thalidomide discontinuation. METHODS: We included 42 patients with multibacillary (MB) leprosy who had episodes of ENL. They were male and female patients aged between 18 and 84 years. RESULTS: Of the 42 patients, 39 (92.85%) had the lepromatous form and three (7.15%) had the borderline form. We found that 100% of patients had no reactional episode during the use of the drug. During the follow-up period after thalidomide discontinuation, 33 (78.57%) patients had no reactional episode and nine (21.43%), all of them with the lepromatous form, had mild episodes, which were controlled using non-steroidal anti-inflammatory. There were no thalidomide-related side effects. CONCLUSION: A maintenance dose of 100 mg/day of thalidomide showed to be effective to prevent repeated type 2 reactional episodes of ENL. .


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Erythema Nodosum/drug therapy , Leprostatic Agents/administration & dosage , Leprosy, Borderline/drug therapy , Leprosy, Lepromatous/drug therapy , Thalidomide/administration & dosage , Dose-Response Relationship, Drug , Erythema Nodosum/prevention & control , Follow-Up Studies , Leprosy, Borderline/prevention & control , Leprosy, Lepromatous/prevention & control , Severity of Illness Index , Sex Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL